COVID-19 During Development: A Matter of Concern
Open Access
- 7 April 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 659032
- https://doi.org/10.3389/fcell.2021.659032
Abstract
A new infectious disease, COVID-19, has spread around the world. The most common symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are cough and fever, but severe cases can develop acute respiratory distress syndrome. The main receptor for SARS-CoV-2 in human tissue is angiotensin-converting enzyme 2, and the lungs, heart, and kidneys are the most affected organs. Besides the inflammatory process and tissue damage, the presence of a cytokine “storm” has been related to a higher mortality rate. Other infectious viral diseases, such as Zika, chikungunya, and influenza, were associated with complications in pregnant women, such as growth restriction, malformation, preterm birth, low birth weight, miscarriage, and death, although they can also cause developmental disorders in infants and adolescents. Evidence points out that stressors during pregnancy and infancy may lead to the development of obesity, diabetes, and cardiovascular disease. Therefore, we hypothesize that COVID-19 infection during the critical phases of development can program the individual to chronic diseases in adulthood. It is important that COVID-19 patients receive proper monitoring as a way to avoid expensive costs to public health in the future.This publication has 100 references indexed in Scilit:
- How can the Developmental Origins of Health and Disease (DOHaD) hypothesis contribute to improving health in developing countries?The American Journal of Clinical Nutrition, 2011
- Causes and Mechanisms of Intrauterine Hypoxia and Its Impact on the Fetal Cardiovascular System: A ReviewInternational Journal of Pediatrics, 2010
- Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analysesBMJ, 2010
- Clinical and economic impact of influenza vaccination on healthy children aged 2–5 yearsVaccine, 2006
- The Developmental Origins of Insulin ResistanceHormone Research in Paediatrics, 2005
- Pregnancy and perinatal outcomes of women with severe acute respiratory syndromeAmerican Journal of Obstetrics and Gynecology, 2004
- Developmental plasticity and human healthNature, 2004
- SARS: epidemiologyRespirology, 2003
- INFANT MORTALITY, CHILDHOOD NUTRITION, AND ISCHAEMIC HEART DISEASE IN ENGLAND AND WALESThe Lancet, 1986
- PULMONARY VENTILATION IN PREGNANCY*BJOG: An International Journal of Obstetrics and Gynaecology, 1978